New antibody drug shows promise in fighting advanced cancers
NCT ID NCT04931654
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 32 times
Summary
This study tests an experimental drug called AZD7789 in people with advanced lung, stomach, or gastroesophageal cancer that has spread. The drug is a bispecific antibody designed to help the immune system attack cancer cells. The main goals are to check safety and see if the drug can shrink tumors or slow cancer growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Atlanta, Georgia, 30322, United States
-
Research Site
Fort Wayne, Indiana, 46804, United States
-
Research Site
New York, New York, 10029, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Toronto, Ontario, M5G 2M9, Canada
-
Research Site
Beijing, 100142, China
-
Research Site
Guangzhou, 510060, China
-
Research Site
Bordeaux, 33076, France
-
Research Site
Rennes, 35000, France
-
Research Site
Villejuif, 94805, France
-
Research Site
Tbilisi, 0112, Georgia
-
Research Site
Chūōku, 104-0045, Japan
-
Research Site
Kashiwa, 277-8577, Japan
-
Research Site
Chisinau, MD-2025, Moldova
-
Research Site
Amsterdam, 1066 CX, Netherlands
-
Research Site
Barcelona, 08035, Spain
-
Research Site
Madrid, 28027, Spain
-
Research Site
Ankara, 06010, Turkey (Türkiye)
-
Research Site
Ankara, 06200, Turkey (Türkiye)
-
Research Site
Ankara, 06800, Turkey (Türkiye)
-
Research Site
Cordaleo, 35575, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.